Income Statement
The income statement presents information on the financial results of a company business activities over a period of time. The income statement communicates how much revenue the company generated during a period and what cost it incurred in connection with generating that revenue.
Paying users area
Try for free
AbbVie Inc. pages available for free this week:
- Statement of Comprehensive Income
- Cash Flow Statement
- Common-Size Income Statement
- Common-Size Balance Sheet: Assets
- Common-Size Balance Sheet: Liabilities and Stockholders’ Equity
- Enterprise Value to FCFF (EV/FCFF)
- Price to FCFE (P/FCFE)
- Capital Asset Pricing Model (CAPM)
- Price to Operating Profit (P/OP) since 2012
- Price to Book Value (P/BV) since 2012
The data is hidden behind: . Unhide it.
Get full access to the entire website from $10.42/mo, or
get 1-month access to AbbVie Inc. for $24.99.
This is a one-time payment. There is no automatic renewal.
We accept:
AbbVie Inc., consolidated income statement
US$ in millions
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).
| Income statement item | Description | The company |
|---|---|---|
| Net revenues | Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise. | AbbVie Inc. net revenues increased from 2021 to 2022 but then decreased significantly from 2022 to 2023. |
| Operating earnings | The net result for the period of deducting operating expenses from operating revenues. | AbbVie Inc. operating earnings increased from 2021 to 2022 but then decreased significantly from 2022 to 2023. |
| Earnings before income tax expense | Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. | AbbVie Inc. earnings before income tax expense increased from 2021 to 2022 but then decreased significantly from 2022 to 2023. |
| Net earnings attributable to AbbVie Inc. | The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. | AbbVie Inc. net earnings attributable to AbbVie Inc. increased from 2021 to 2022 but then decreased significantly from 2022 to 2023. |